<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35020042</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-086X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cardiovascular and interventional radiology</Title>
          <ISOAbbreviation>Cardiovasc Intervent Radiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding.</ArticleTitle>
        <Pagination>
          <StartPage>542</StartPage>
          <EndPage>549</EndPage>
          <MedlinePgn>542-549</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00270-021-03040-8</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study compares the safety and efficacy of the ePTFE-covered self-expansible nitinol stent (VIATORR® Controlled Expansion, Gore, Flagstaff, USA) with the ePTFE-covered, balloon-expandable, metallic stent (BeGraft peripheral, Bentley, Hechingen, Germany) for the creation of the transjugular intrahepatic portosystemic shunt (TIPS).</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">From September 2016 to December 2020, 72 consecutive patients receiving TIPS for acute variceal bleeding (rescue and early TIPS, n = 15) or for prophylaxis of variceal rebleeding (n = 57) were enrolled. The main contraindications were patients with vascular liver disease (portal vein thrombosis and Budd-Chiari syndrome). Forty patients (55.6%) received a Viatorr CX stent and 32 patients (44.4%) a BeGraft peripheral stent. Safety endpoints were technical and clinical adverse events and early deaths within 30 days after TIPS implantation. Efficacy endpoints were rebleeding rates, recurrence of large varices requiring endoscopic band ligation, or TIPS revision.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Groups receiving the Viatorr CX or BeGraft peripheral stent were comparable in all respects except the TIPS indication for acute variceal bleeding (5% vs. 25%, p = 0.015). All patients had a successful intervention, and the physical variables of stent implantation (intervention and fluoroscopy time, reduction of the portosystemic pressure gradient) as well as adjunctive embolization of varices were similar in both groups. Severe clinical complications (Viatorr CX: 5% vs. BeGraft peripheral: 3.1%, p = 0.692), post-TIPS hepatic encephalopathy (12.5% vs. 18.8%, p = 0.743) and death (5% vs. 0%, p = 0.793) were not different between Viatorr CX and BeGraft peripheral groups. With respect to efficacy, freedom from rebleeding and from variceal band ligation during follow-up (100% vs. 100%, p = 1.0), as well as the need for shunt revision (10.5% vs. 18.8%, p = 0.327), was comparable.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Compared to the present gold standard, the Viatorr CX stent, the balloon-expandable BeGraft peripheral stent, showed similar results with respect to safety and efficacy.</AbstractText>
          <CopyrightInformation>© 2021. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Schultheiss</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-8000-1721</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Bettinger</LastName>
            <ForeName>Dominik</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sturm</LastName>
            <ForeName>Lukas</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmidt</LastName>
            <ForeName>Arthur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Backhus</LastName>
            <ForeName>Johanna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine I, Faculty of Medicine, Medical Center University of Ulm, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Waidmann</LastName>
            <ForeName>Oliver</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine I, Faculty of Medicine, Medical Center University of Frankfurt, University of Frankfurt, Theodor-Stern-Kai 7, 60596, Frankfurt am Main, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Radecke</LastName>
            <ForeName>Klaus</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Klinik Für Innere Medizin I, Klinikum Saarbrücken, Saarbrücken, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grandt</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Klinik Für Innere Medizin I, Klinikum Saarbrücken, Saarbrücken, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thimme</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg im Breisgau, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rössle</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine II, Faculty of Medicine, Medical Center University of Freiburg, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg im Breisgau, Germany. martin-roessle@t-online.de.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cardiovasc Intervent Radiol</MedlineTA>
        <NlmUniqueID>8003538</NlmUniqueID>
        <ISSNLinking>0174-1551</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>9002-84-0</RegistryNumber>
          <NameOfSubstance UI="D011138">Polytetrafluoroethylene</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004932" MajorTopicYN="Y">Esophageal and Gastric Varices</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006975" MajorTopicYN="Y">Hypertension, Portal</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011138" MajorTopicYN="N">Polytetrafluoroethylene</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019168" MajorTopicYN="Y">Portasystemic Shunt, Transjugular Intrahepatic</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015607" MajorTopicYN="N">Stents</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014648" MajorTopicYN="Y">Varicose Veins</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Balloon-expandable stent</Keyword>
        <Keyword MajorTopicYN="N">Complications</Keyword>
        <Keyword MajorTopicYN="N">Nitinol</Keyword>
        <Keyword MajorTopicYN="N">Patency</Keyword>
        <Keyword MajorTopicYN="N">Self-expandable stent</Keyword>
        <Keyword MajorTopicYN="N">Transjugular intrahepatic portosystemic shunt (TIPS)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>12</Day>
          <Hour>12</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35020042</ArticleId>
        <ArticleId IdType="doi">10.1007/s00270-021-03040-8</ArticleId>
        <ArticleId IdType="pii">10.1007/s00270-021-03040-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rössle M. TIPS: 25 years later. J Hepatol. 2013;59:1081–93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2013.06.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schultheiβ M, Bettinger D, Thimme R, Rössle M. 30 Years of transjugular intrahepatic portosystemic shunt (TIPS): casting a retrospective glance and future perspectives. Z Gastroenterol. 2020;58:877–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1217-7866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tripathi D, Stanley AJ, Hayes PC, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680–704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-309262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology. 2010;51:306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.23383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Franchis R, Abraldes JG, Bajaj J, et al. Expanding consensus in portal hypertension report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2015.05.022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boike JR, Thornburg BG, Asrani SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension. Clin Gastroenterol Hepatol. 2021;S1542–3565(21):00749–57.</Citation>
        </Reference>
        <Reference>
          <Citation>Mollaiyan A, Bettinger D, Rössle M. The underdilation of nitinol stents at TIPS implantation: solution or illusion? Eur J Radiol. 2017;89:123–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejrad.2017.01.032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pieper CC, Sprinkart AM, Nadal J, et al. Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents. J Vasc Interv Radiol. 2015;26:388–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jvir.2014.10.021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaba RC, Parvinian A, Minocha J, et al. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated? J Vasc Interv Radiol. 2015;26:382–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jvir.2014.08.012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borghol S, Perarnau JM, Pucheux J, et al. Short- and long-term evolution of the endoluminal diameter of underdilated stents in transjugular intrahepatic portosystemic shunt. Diagn Interv Imaging. 2016;97:1103–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diii.2016.06.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haskal ZJ, Pentecost MJ, Soulen MC, et al. Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. Am J Roentgenol. 1994;163:439–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.163.2.8037046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rössle M, Maruschke L, Radecke K, et al. Usefulness of a balloon-expandable, covered stent for the transjugular intrahepatic portosystemic shunt. J Radiol Imaging. 2018;3:1–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14312/2399-8172.2018-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krajina A, Lojik M, Chovanec V, et al. Stent-grafts in TIPS. Abdom Imaging. 2004;29:53–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-003-0100-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaBerge JM, Ferrell LD, Ring EJ, et al. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1991;2:549–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1051-0443(91)72241-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stout LC, Lyon RE, Murray GB, et al. Pseudointimal biliary epithelial proliferation and Zahn’s infarct associated with a 6 1/2-month-old transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 1995;90:126–30.</Citation>
        </Reference>
        <Reference>
          <Citation>Jalan R, Harrison DJ, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt (TIFSS) occlusion and the role of biliary venous fistulae. J Hepatol. 1996;24:169–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-8278(96)80026-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanyal AJ, Contos MJ, Yager D, et al. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. Hepatology. 1998;28:22–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.510280105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teng GJ, Bettmann MA, Hoopes PJ, et al. Transjugular intrahepatic portosystemic shunt: effect of bile leak on smooth muscle cell proliferation. Radiology. 1998;208:799–805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.208.3.9722863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE- covered stent-grafts: experimental results in swine. Radiology. 1995;196:341–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.196.2.7617843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haskal ZJ, Davis A, McAllister A, Furth EE. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation. Radiology. 1997;205:682–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.205.3.9393521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otal P, Rousseau H, Vinel JP, et al. High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a dacron-covered nitinol stent. J Vasc Interv Radiol. 1999;10:183–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1051-0443(99)70463-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haskal ZJ, Brennecke LH. Transjugular intrahepatic portosystemic shunts formed with polyethylene terephthalate-covered stents: experimental evaluation in pigs. Radiology. 1999;213:853–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.213.3.r99dc24853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bloch R, Pavcnik D, Uchida BT, et al. Polyurethane-coated dacron-covered stentgrafts for tips: results in swine. Cardiovasc Intervent Radiol. 1998;21:497–500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s002709900310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanihata H, Saxon RR, Kubota Y, et al. Transjugular intrahepatic portosystemic shunt with silicone-covered wallstents: results in a swine model. Radiology. 1997;205:181–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.205.1.9314982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haskal ZJ, Brennecke LJ. Porous and nonporous polycarbonate urethane stent-grafts for TIPS formation: biologic responses. J Vasc Interv Radiol. 1999;10:1255–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1051-0443(99)70228-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuang ZW, Hoopes PJ, Koutras PC, et al. Transjugular intrahepatic portosystemic shunt with an autologous vein-covered stent: results in a swine model. J Vasc Interv Radiol. 2001;12:1333–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1051-0443(07)61560-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wittkugel O, Koops A, Habermann CR, et al. Bile resistance of coated transjugular intrahepatic portosystemic shunt stents in a flow-model. Invest Radiol. 2004;39:717–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00004424-200412000-00002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330:165–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199401203300303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver. 1998;18:73–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0676.1998.tb00132.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00270-017-1703-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-8278(00)80320-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rössle M, Blanke P, Fritz B, et al. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol. 2016;27:1130–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jvir.2016.03.028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conn HO. Hepatic encephalopathy. In: L Schiff ES (Hrsg.). Diseases of the Liver, 7th ed. Philadelphia, PA, 1993:1036–1060</Citation>
        </Reference>
        <Reference>
          <Citation>Bettinger D, Sturm L, Pfaff L, et al. Refining prediction of survival in TIPS patients: the freiburg index of post-TIPS survival (FIPS). J Hepatol. 2021;74:1362–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2021.01.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trebicka J, Bastgen D, Byrtus J, et al. Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival. Clin Gastroenterol Hepatol. 2019;17:2793-2799.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2019.03.042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sauerbruch T, Mengel M, Dollinger M, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology. 2015;149:660e1-668e.1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2015.05.011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holster IL, Tjwa ETTL, Moelker A, et al. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+β-blocker for prevention of variceal rebleeding. Hepatology. 2016;63:581–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.28318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa0910102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudler M, Cluzel P, Corvec TL, et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014;40:1074–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.12934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X, Ding W, Cao J, et al. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension. Am Surg. 2013;79:305–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/000313481307900332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad WEA, Darwish WM, Davies MG, Waldman DL. Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. J Vasc Interv Radiol. 2010;21:1512–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jvir.2010.06.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsauo J, Li X. Viatorr TIPS endoprosthesis versus generic expanded polytetrafluoroethylene-covered stent-grafts. Am J Roentgenol. 2015;205:W463–W463.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.15.14757</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
